NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

Balamidas {Welcome}, you wrote:

the S-3 gives them the authority thus the possibility to raise cash for the trials

It seems logical to me that at least part of this new shelf agreement would indeed relate to "the possibility to raise cash for the trials".
Specifically,
It seems that NWBO recently indicated that they could keep their funding needs at a low level, until such time as it became imminent for the combo trials to commence, at which time they would need to do aggressive fund raising. Perhaps this new shelf filing relates this? Perhaps BP will pick up a good part of the tab, but perhaps NWBO will still need to come up with a big chunk too?